Correlation of Obesity and Osteoporosis: Effect of Fat Mass on the Determination of Osteoporosis
暂无分享,去创建一个
H. Deng | D. Maulik | C. Papasian | Lan-Juan Zhao | B. Drees | J. Hamilton | Hui Jiang | James J. Hamilton
[1] G. Steinberg,et al. Adipose tissue as an endocrine organ , 2010, Molecular and Cellular Endocrinology.
[2] R. Recker,et al. Relationship of obesity with osteoporosis. , 2007, The Journal of clinical endocrinology and metabolism.
[3] S. Allison,et al. The control of bone remodeling by neuropeptide Y receptors , 2007, Peptides.
[4] J. Gimble,et al. Bone and fat , 2004, Endocrine.
[5] C. Christiansen,et al. The role of serum concentrations of sex steroids and bone turnover in the development and occurrence of postmenopausal osteoporosis , 1986, Calcified Tissue International.
[6] I. Reid,et al. Preptin, another peptide product of the pancreatic beta-cell, is osteogenic in vitro and in vivo. , 2007, American journal of physiology. Endocrinology and metabolism.
[7] T. Wren,et al. Fat mass is not beneficial to bone in adolescents and young adults. , 2007, The Journal of clinical endocrinology and metabolism.
[8] B. Komm,et al. Wnt signaling and osteoblastogenesis , 2007, Reviews in Endocrine and Metabolic Disorders.
[9] C. Anderson,et al. Antiobesity effects of the beta-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression. , 2006, Endocrinology.
[10] M. Goran,et al. Racial Differences in the Association of Subcutaneous and Visceral Fat on Bone Mineral Content in Prepubertal Children , 2006, Calcified Tissue International.
[11] G. Karsenty,et al. Convergence between bone and energy homeostases: leptin regulation of bone mass. , 2006, Cell metabolism.
[12] J. Reseland,et al. Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism , 2006, Journal of cellular biochemistry.
[13] E. Hennig,et al. Musculoskeletal disorders associated with obesity: a biomechanical perspective , 2006, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[14] J. Gimble,et al. Playing with bone and fat , 2006, Journal of cellular biochemistry.
[15] Guo-xian Ding,et al. Role of 11-beta-hydroxysteroid dehydrogenase type 1 in differentiation of 3T3-L1 cells and in rats with diet-induced obesity , 2006, Acta Pharmacologica Sinica.
[16] J. Mao,et al. Comparison of Osteogenic Potentials of Visceral and Subcutaneous Adipose-Derived Cells of Rabbits , 2006, Plastic and reconstructive surgery.
[17] M. Eijken,et al. The essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralization , 2006, Molecular and Cellular Endocrinology.
[18] M. Cohen. Role of leptin in regulating appetite, neuroendocrine function, and bone remodeling , 2006, American journal of medical genetics. Part A.
[19] Mary L Bouxsein,et al. Mechanisms of Disease: is osteoporosis the obesity of bone? , 2006, Nature Clinical Practice Rheumatology.
[20] T. Niu,et al. Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women. , 2006, The American journal of clinical nutrition.
[21] M. Malaise,et al. Interleukin-6: An osteotropic factor influencing bone formation? , 2005, Bone.
[22] H. Xie,et al. Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. , 2005, Experimental cell research.
[23] E. Wagner,et al. The Molecular Clock Mediates Leptin-Regulated Bone Formation , 2005, Cell.
[24] M. Lafage-Proust,et al. Leptin modulates both resorption and formation while preventing disuse-induced bone loss in tail-suspended female rats. , 2005, Endocrinology.
[25] P. Stewart,et al. 11β-Hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action , 2005 .
[26] Won-Young Lee,et al. The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle‐aged men , 2005, Clinical endocrinology.
[27] J. Glowacki,et al. Hypoxia Inhibition of Adipocytogenesis in Human Bone Marrow Stromal Cells Requires Transforming Growth Factor-β/Smad3 Signaling* , 2005, Journal of Biological Chemistry.
[28] M. Matsuda,et al. Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. , 2005, Biochemical and biophysical research communications.
[29] H. Kroger,et al. Body mass index as a predictor of fracture risk: A meta-analysis , 2005, Osteoporosis International.
[30] J. Jürimäe,et al. Adiponectin is Associated with Bone Mineral Density in Perimenopausal Women , 2005, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[31] John J. Shin,et al. Differential effect of obesity on bone mineral density in White, Hispanic and African American women: a cross sectional study , 2005, Nutrition & metabolism.
[32] A. Uitterlinden,et al. 11β-Hydroxysteroid Dehydrogenase Expression and Glucocorticoid Synthesis Are Directed by a Molecular Switch during Osteoblast Differentiation , 2005 .
[33] Masaki Noda,et al. Leptin regulation of bone resorption by the sympathetic nervous system and CART , 2005, Nature.
[34] M. St-Onge. Dietary fats, teas, dairy, and nuts: potential functional foods for weight control? , 2005, The American journal of clinical nutrition.
[35] S. Kato,et al. Nuclear receptors as targets for drug development: crosstalk between peroxisome proliferator-activated receptor gamma and cytokines in bone marrow-derived mesenchymal stem cells. , 2005, Journal of pharmacological sciences.
[36] J. Seckl. 11beta-hydroxysteroid dehydrogenases: changing glucocorticoid action. , 2004, Current opinion in pharmacology.
[37] B. Lecka-Czernik,et al. Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR‐γ2 transcription factor and TGF‐β/BMP signaling pathways , 2004, Aging cell.
[38] Matthew R. Smith. Osteoporosis and obesity in men receiving hormone therapy for prostate cancer. , 2004, The Journal of urology.
[39] S. Farmer,et al. Regulating the Balance between Peroxisome Proliferator-activated Receptor γ and β-Catenin Signaling during Adipogenesis , 2004, Journal of Biological Chemistry.
[40] C. Drevon,et al. Adiponectin and its receptors are expressed in bone-forming cells. , 2004, Bone.
[41] Jeremy W Tomlinson,et al. 11 (cid:1) -Hydroxysteroid Dehydrogenase Type 1: A Tissue-Specific Regulator of Glucocorticoid Response , 2004 .
[42] A. Rissanen,et al. Overexpression of 11beta-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins. , 2004, The Journal of clinical endocrinology and metabolism.
[43] H. Herzog,et al. NPY and Y receptors: lessons from transgenic and knockout models , 2004, Neuropeptides.
[44] T. Thomas. The complex effects of leptin on bone metabolism through multiple pathways. , 2004, Current opinion in pharmacology.
[45] C. Gutiérrez,et al. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. , 2004, Obesity research.
[46] M. Zemel,et al. Role of calcium and dairy products in energy partitioning and weight management. , 2004, The American journal of clinical nutrition.
[47] A. Madan,et al. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. , 2004, Endocrinology.
[48] P. Sassone-Corsi,et al. ATF4 Is a Substrate of RSK2 and an Essential Regulator of Osteoblast Biology Implication for Coffin-Lowry Syndrome , 2004, Cell.
[49] U. Dafni,et al. Blood Leptin and Adiponectin as Possible Mediators of the Relation Between Fat Mass and BMD in Perimenopausal Women , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[50] Kozo Nakamura,et al. PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. , 2004, The Journal of clinical investigation.
[51] P. Tontonoz,et al. Fat's loss is bone's gain. , 2004, The Journal of clinical investigation.
[52] D. Xie,et al. Leptin deficiency produces contrasting phenotypes in bones of the limb and spine. , 2004, Bone.
[53] I. Reid. Leptin deficiency--lessons in regional differences in the regulation of bone mass. , 2004, Bone.
[54] C. Laplace,et al. Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo , 2004, The Journal of cell biology.
[55] T. Martin,et al. Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways. , 2004, The Journal of clinical investigation.
[56] J. Glowacki,et al. Cooperation Between TGF‐β and Wnt Pathways During Chondrocyte and Adipocyte Differentiation of Human Marrow Stromal Cells , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[57] G. Sukhikh,et al. Mesenchymal Stem Cells , 2002, Bulletin of Experimental Biology and Medicine.
[58] Arya M. Sharma,et al. Regulation of 11β‐HSD Genes in Human Adipose Tissue: Influence of Central Obesity and Weight Loss , 2004 .
[59] S. Farmer,et al. Regulating the balance between peroxisome proliferator-activated receptor gamma and beta-catenin signaling during adipogenesis. A glycogen synthase kinase 3beta phosphorylation-defective mutant of beta-catenin inhibits expression of a subset of adipogenic genes. , 2004, The Journal of biological chemistry.
[60] Laura Maffei,et al. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. , 2004, The Journal of clinical endocrinology and metabolism.
[61] B. Walker,et al. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase in adipose tissue. , 2004, Recent progress in hormone research.
[62] L. Mosekilde,et al. Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis , 2004, Biogerontology.
[63] Stanley B. Cohen,et al. Oral glucocorticoid use is associated with an increased risk of fracture , 2004, Osteoporosis International.
[64] H. Herzog. Neuropeptide Y and energy homeostasis: insights from Y receptor knockout models. , 2003, European journal of pharmacology.
[65] K. Lohman,et al. Adiponectin as a novel determinant of bone mineral density and visceral fat. , 2003, Bone.
[66] C. Schwarzer,et al. Synergistic Effects of Y2 and Y4 Receptors on Adiposity and Bone Mass Revealed in Double Knockout Mice , 2003, Molecular and Cellular Biology.
[67] R. Eastell,et al. 11β-Hydroxysteroid Dehydrogenase Type 1 Activity Predicts the Effects of Glucocorticoids on Bone , 2003 .
[68] L. Melton,et al. Adverse Outcomes of Osteoporotic Fractures in the General Population , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[69] J. Fernández-Real,et al. Insulin resistance and chronic cardiovascular inflammatory syndrome. , 2003, Endocrine reviews.
[70] J. A. Robinson,et al. High Bone Mass in Mice Expressing a Mutant LRP5 Gene , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[71] R. Recker,et al. Molecular and genetic mechanisms of obesity: implications for future management. , 2003, Current molecular medicine.
[72] W. Rand,et al. Leptin, Body Composition and Bone Mineral Density in Premenopausal Women , 2003, Calcified Tissue International.
[73] C. Mantzoros,et al. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. , 2003, The Journal of clinical endocrinology and metabolism.
[74] T. Thomas. Leptin: a potential mediator for protective effects of fat mass on bone tissue. , 2003, Joint, bone, spine : revue du rhumatisme.
[75] P. Vestergaard,et al. Hormone Replacement Therapy Dissociates Fat Mass and Bone Mass, and Tends to Reduce Weight Gain in Early Postmenopausal Women: A Randomized Controlled 5‐Year Clinical Trial of the Danish Osteoporosis Prevention Study , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[76] J. Després,et al. The interleukin 6 –174G/C Polymorphism is associated with indices of obesity in men , 2003, Journal of Human Genetics.
[77] A. Mokdad,et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. , 2003, JAMA.
[78] I. Reid. Relationships among body mass, its components, and bone. , 2002, Bone.
[79] Patricia Ducy,et al. Leptin Regulates Bone Formation via the Sympathetic Nervous System , 2002, Cell.
[80] P. Hees,et al. Fitness, fatness and activity as predictors of bone mineral density in older persons , 2002, Journal of internal medicine.
[81] D. Giannella‐Neto,et al. Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome. , 2002, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[82] I. Reid,et al. Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. , 2002, The Journal of endocrinology.
[83] A. Geliebter,et al. Amylin, food intake, and obesity. , 2002, Obesity research.
[84] J. Cornish,et al. Amylin and adrenomedullin: novel regulators of bone growth. , 2002, Current pharmaceutical design.
[85] B. Burguera,et al. Is Leptin the Link Between Fat and Bone Mass? , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[86] David E. Misek,et al. Microarray Analyses during Adipogenesis: Understanding the Effects of Wnt Signaling on Adipogenesis and the Roles of Liver X Receptor α in Adipocyte Metabolism , 2002, Molecular and Cellular Biology.
[87] Charles Kooperberg,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.
[88] T. Hökfelt,et al. Important role of hypothalamic Y2 receptors in body weight regulation revealed in conditional knockout mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[89] J. Kirkland,et al. Adipogenesis and aging: does aging make fat go MAD? , 2002, Experimental Gerontology.
[90] M. Cooper,et al. Osteoblastic 11β‐Hydroxysteroid Dehydrogenase Type 1 Activity Increases With Age and Glucocorticoid Exposure , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[91] Toshio Matsumoto,et al. Estrogen Promotes Early Osteoblast Differentiation and Inhibits Adipocyte Differentiation in Mouse Bone Marrow Stromal Cell Lines That Express Estrogen Receptor (er) ␣ or  , 2022 .
[92] J. Lehmann,et al. Printed in U.S.A. Copyright © 2002 by The Endocrine Society Divergent Effects of Selective Peroxisome Proliferator- Activated Receptor-�2 Ligands on Adipocyte Versus Osteoblast Differentiation , 2022 .
[93] Richard P Lifton,et al. High bone density due to a mutation in LDL-receptor-related protein 5. , 2002, The New England journal of medicine.
[94] Ivan Lobov,et al. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor , 2002, The Journal of cell biology.
[95] G. Thomas,et al. Hypothalamic Y2 receptors regulate bone formation. , 2002, The Journal of clinical investigation.
[96] Mark L. Johnson,et al. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. , 2002, American journal of human genetics.
[97] J. Lehmann,et al. Divergent Effects of Selective Peroxisome Proliferator-Activated Receptor- (cid:1) 2 Ligands on Adipocyte Versus Osteoblast Differentiation , 2002 .
[98] Toshio Matsumoto,et al. Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) alpha or beta. , 2002, Endocrinology.
[99] L. Rossetti,et al. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. , 2001, The Journal of clinical investigation.
[100] C. Buchanan,et al. Preptin derived from proinsulin-like growth factor II (proIGF-II) is secreted from pancreatic islet beta-cells and enhances insulin secretion. , 2001, The Biochemical journal.
[101] Miikka Vikkula,et al. LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development , 2001, Cell.
[102] M. Mędraś,et al. Are general obesity and visceral adiposity in men linked to reduced bone mineral content resulting from normal ageing? A population‐based study , 2001, Andrologia.
[103] M. Visser,et al. Determinants of Bone Mineral Density in Older Men and Women: Body Composition as Mediator , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[104] U. Das. Is obesity an inflammatory condition? , 2001, Nutrition.
[105] Sheila M. Williams,et al. Bone mineral density and body composition in boys with distal forearm fractures: a dual-energy x-ray absorptiometry study. , 2001, The Journal of pediatrics.
[106] B. Ottesen,et al. Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy. , 2001, Obesity research.
[107] L. Melton,et al. The Prevalence of Osteoporosis: Gender and Racial Comparison , 2001, Calcified Tissue International.
[108] B. Wisse,et al. Role of melanocortins in control of obesity , 2001, The Lancet.
[109] K. Chihara,et al. Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women , 2001, Clinical endocrinology.
[110] A. Genazzani,et al. Prospective evaluation of body weight and body fat distribution in early postmenopausal women with and without hormonal replacement therapy. , 2001, Maturitas.
[111] P. Scherer,et al. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action , 2001, Nature Medicine.
[112] J. Manson,et al. Clinical practice. Postmenopausal hormone-replacement therapy. , 2001, The New England journal of medicine.
[113] P. Heine,et al. The role of estrogen and estrogen receptor-α in male adipose tissue , 2001, Molecular and Cellular Endocrinology.
[114] J. Hopper,et al. Changes in Body Composition as Determinants of Longitudinal Changes in Bone Mineral Measures in 8 to 26-year-old Female Twins , 2001, Osteoporosis International.
[115] Jeannie S. Huang,et al. Increased abdominal visceral fat is associated with reduced bone density in HIV-infected men with lipodystrophy , 2001, AIDS.
[116] T. Funahashi,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance , 2022 .
[117] J. Pasco,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Serum Leptin Levels Are Associated with Bone Mass in , 2022 .
[118] T. Olsson,et al. Tissue-specific dysregulation of cortisol metabolism in human obesity. , 2001, The Journal of clinical endocrinology and metabolism.
[119] M. Lazar,et al. The hormone resistin links obesity to diabetes , 2001, Nature.
[120] P. Heine,et al. The role of estrogen and estrogen receptor-alpha in male adipose tissue. , 2001, Molecular and cellular endocrinology.
[121] H. Hsiung,et al. Absence of cocaine- and amphetamine-regulated transcript results in obesity in mice fed a high caloric diet. , 2001, Endocrinology.
[122] A. Astrup,et al. Obesity : Preventing and managing the global epidemic , 2000 .
[123] B. Wajchenberg. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. , 2000, Endocrine reviews.
[124] G. Iwamoto,et al. Increased adipose tissue in male and female estrogen receptor-α knockout mice , 2000 .
[125] Yoichi Kato,et al. LDL-receptor-related proteins in Wnt signal transduction , 2000, Nature.
[126] M. Cooper,et al. Expression and functional consequences of 11beta-hydroxysteroid dehydrogenase activity in human bone. , 2000, Bone.
[127] C. Steppan,et al. Leptin is a potent stimulator of bone growth in ob/ob mice , 2000, Regulatory Peptides.
[128] D. Pennica,et al. Stimulation of osteoclast differentiation in vitro by mouse oncostatin M, leukaemia inhibitory factor, cardiotrophin-1 and interleukin 6: synergy with dexamethasone. , 2000, Cytokine.
[129] T. Douchi,et al. Relationship Between Body Fat Distribution and Bone Mineral Density in Premenopausal Japanese Women , 2000, Obstetrics and gynecology.
[130] P. Kopelman. Obesity as a medical problem , 2000, Nature.
[131] Arndt F Schilling,et al. Leptin Inhibits Bone Formation through a Hypothalamic Relay A Central Control of Bone Mass , 2000, Cell.
[132] B. Walker,et al. Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. , 2000, Endocrinology.
[133] G. Iwamoto,et al. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[134] J. Woo,et al. Vertebral Deformity in Chinese Men: Prevalence, Risk Factors, Bone Mineral Density, and Body Composition Measurements , 2000, Calcified Tissue International.
[135] C. Christiansen,et al. Low Body Mass Index Is an Important Risk Factor for Low Bone Mass and Increased Bone Loss in Early Postmenopausal Women , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[136] T. Rönnemaa,et al. Bone mineral density in patients with type 1 and type 2 diabetes. , 1999, Diabetes care.
[137] K. Hotta,et al. Age-related adipose tissue mRNA expression of ADD1/SREBP1, PPARgamma, lipoprotein lipase, and GLUT4 glucose transporter in rhesus monkeys. , 1999, The journals of gerontology. Series A, Biological sciences and medical sciences.
[138] C. Mantzoros. The Role of Leptin in Human Obesity and Disease: A Review of Current Evidence , 1999, Annals of Internal Medicine.
[139] M. Jensen,et al. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. , 1999, Endocrinology.
[140] R. Oreffo,et al. Effects of TGFβ and BFGF on the differentiation of human bone marrow stromal fibroblasts , 1999, Cell biology international.
[141] JC Seidell,et al. Obesity: a growing problem , 1999, Acta paediatrica (Oslo, Norway : 1992). Supplement.
[142] L. Khaodhiar,et al. Obesity and its comorbid conditions. , 1999, Clinical cornerstone.
[143] C. Marcelli,et al. Evolution of Lumbar Bone Mineral Content During Adolescence and Adulthood: A Longitudinal Study in 395 Healthy Females 10–24 Years of Age and 206 Premenopausal Women , 1999, Osteoporosis International.
[144] A. Goulding,et al. Plasma Leptin Values in Relation to Bone Mass and Density and to Dynamic Biochemical Markers of Bone Resorption and Formation in Postmenopausal Women , 1998, Calcified Tissue International.
[145] S. C. Lin,et al. Interleukin-6-type cytokines stimulate mesenchymal progenitor differentiation toward the osteoblastic lineage. , 1998, Proceedings of the Association of American Physicians.
[146] J. Halaas,et al. Leptin and the regulation of body weight in mammals , 1998, Nature.
[147] B. L. Riggs,et al. A Unitary Model for Involutional Osteoporosis: Estrogen Deficiency Causes Both Type I and Type II Osteoporosis in Postmenopausal Women and Contributes to Bone Loss in Aging Men , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[148] T. Hangartner,et al. Relation of nutrition, body composition and physical activity to skeletal development: a cross-sectional study in preadolescent females. , 1998, Journal of the American College of Nutrition.
[149] G A Colditz,et al. Current estimates of the economic cost of obesity in the United States. , 1998, Obesity research.
[150] H. Sul,et al. Understanding adipocyte differentiation. , 1998, Physiological reviews.
[151] J. Callés-Escandon,et al. Menopause, central body fatness, and insulin resistance: effects of hormone‐replacement therapy , 1998, Coronary artery disease.
[152] Edwards,et al. 11 b-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress , 1997 .
[153] T. Douchi,et al. The effect of body composition on bone density in pre- and postmenopausal women. , 1997, Maturitas.
[154] P. Stewart,et al. Does central obesity reflect “Cushing's disease of the omentum”? , 1997, The Lancet.
[155] M. Aickin,et al. Fat or Lean Tissue Mass: Which One Is the Major Determinant of Bone Mineral Mass in Healthy Postmenopausal Women? , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[156] L. Melton,et al. Medical Expenditures for the Treatment of Osteoporotic Fractures in the United States in 1995: Report from the National Osteoporosis Foundation , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[157] B. Tarquini,et al. Evidence for bone mass and body fat distribution relationship in postmenopausal obese women. , 1997, Archives of gerontology and geriatrics.
[158] E. Barrett-Connor,et al. Does Hyperinsulinemia Preserve Bone? , 1996, Diabetes Care.
[159] I. Reid. Therapy of osteoporosis: calcium, vitamin D, and exercise. , 1996, The American journal of the medical sciences.
[160] J. Lehmann,et al. Peroxisome proliferator-activated receptor-gamma activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells. , 1996, Molecular pharmacology.
[161] L. Melton,et al. Relationship between body composition and bone mass in women , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[162] A. Hofman,et al. Hyperinsulinemia and bone mineral density in an elderly population: The Rotterdam Study. , 1996, Bone.
[163] Su‐Li Cheng,et al. Expression of bone matrix proteins during dexamethasone‐induced mineralization of human bone marrow stromal cells , 1996, Journal of cellular biochemistry.
[164] I. Sartori. Increasing Prevalence of Overweight Among US Adults , 1996 .
[165] E. Simpson,et al. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. , 1995, The Journal of clinical endocrinology and metabolism.
[166] C Milgrom,et al. Aging and matrix microdamage accumulation in human compact bone. , 1995, Bone.
[167] I. Reid,et al. Regular exercise dissociates fat mass and bone density in premenopausal women. , 1995, The Journal of clinical endocrinology and metabolism.
[168] C. Heiss,et al. Associations of body fat distribution, circulating sex hormones, and bone density in postmenopausal women. , 1995, The Journal of clinical endocrinology and metabolism.
[169] M. Maffei,et al. Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.
[170] M. Maffei,et al. Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.
[171] K. Korach,et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. , 1994, The New England journal of medicine.
[172] I. Reid,et al. Determinants of the rate of bone loss in normal postmenopausal women. , 1994, The Journal of clinical endocrinology and metabolism.
[173] R. Marcus,et al. Correlates of bone mineral density in the postmenopausal estrogen/progestin interventions trial , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[174] K. Flegal,et al. Increasing Prevalence of Overweight Among US Adults: The National Health and Nutrition Examination Surveys, 1960 to 1991 , 1994 .
[175] Lynda F. Bonewald,et al. Role of active and latent transforming growth factor β in bone formation , 1994 .
[176] R. Dodds,et al. Expression of mRNA for IL1 beta, IL6 and TGF beta 1 in developing human bone and cartilage. , 1994, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[177] J. Wozney,et al. Transforming Growth Factor-β Gene Family Members and Bone* , 1994 .
[178] L. Bonewald,et al. Role of active and latent transforming growth factor beta in bone formation. , 1994, Journal of cellular biochemistry.
[179] J. Wozney,et al. Transforming growth factor-beta gene family members and bone. , 1994, Endocrine reviews.
[180] K. Martin,et al. Postmenopausal hormone-replacement therapy. , 2001, The New England journal of medicine.
[181] C C Glüer,et al. Simple measurement of femoral geometry predicts hip fracture: The study of osteoporotic fractures , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[182] W. O'Fallon,et al. Long‐term fracture prediction by bone mineral assessed at different skeletal sites , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[183] J J Anderson,et al. Effects of weight and body mass index on bone mineral density in men and women: The framingham study , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[184] S. Cummings,et al. Bone density at various sites for prediction of hip fractures , 1993, The Lancet.
[185] I. Reid,et al. Fat mass is an important determinant of whole body bone density in premenopausal women but not in men. , 1992, The Journal of clinical endocrinology and metabolism.
[186] I. Reid,et al. Determinants of total body and regional bone mineral density in normal postmenopausal women--a key role for fat mass. , 1992, The Journal of clinical endocrinology and metabolism.
[187] G. Rodan. Introduction to bone biology. , 1992, Bone.
[188] M. Wabitsch,et al. Control of terminal differentiation of adipose precursor cells by glucocorticoids. , 1991, Journal of lipid research.
[189] R. Mazess,et al. Spine and femur density using dual-photon absorptiometry in US white women. , 1987, Bone and mineral.
[190] H. Spencer,et al. Factors Contributing to Osteoporosis , 1986 .
[191] H. Spencer,et al. NIH Consensus Conference: osteoporosis. Factors contributing to osteoporosis. , 1986, The Journal of nutrition.
[192] T. Bartness,et al. Gonadal influences on adiposity. , 1985, International journal of obesity.